| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.02T | 996.35B | 941.17B | 868.69B | 853.06B | 717.29B |
| Gross Profit | 414.37B | 398.06B | 354.85B | 318.99B | 313.61B | 296.08B |
| EBITDA | 129.86B | 207.51B | 164.01B | 153.11B | 128.23B | 217.96B |
| Net Income | 90.61B | 130.11B | 80.01B | 72.78B | 62.25B | 150.58B |
Balance Sheet | ||||||
| Total Assets | 1.88T | 1.80T | 1.76T | 1.75T | 1.70T | 1.69T |
| Cash, Cash Equivalents and Short-Term Investments | 380.62B | 428.09B | 571.03B | 524.47B | 455.08B | 483.44B |
| Total Debt | 262.85B | 248.11B | 205.61B | 195.57B | 176.60B | 181.44B |
| Total Liabilities | 772.70B | 714.12B | 652.23B | 630.12B | 613.36B | 606.58B |
| Stockholders Equity | 1.04T | 1.01T | 986.54B | 989.66B | 948.48B | 937.47B |
Cash Flow | ||||||
| Free Cash Flow | -60.39B | 78.16B | 150.82B | 165.52B | 87.95B | 181.96B |
| Operating Cash Flow | 92.23B | 164.82B | 184.01B | 199.90B | 140.39B | 223.63B |
| Investing Cash Flow | -134.23B | -206.61B | -26.27B | -137.20B | -190.54B | -235.79B |
| Financing Cash Flow | 10.93B | -57.12B | -104.81B | -64.07B | -68.13B | 29.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$33.48B | -17.03 | 11.27% | 3.18% | 26.38% | -53.61% | |
64 Neutral | HK$350.41B | 13.49 | 8.57% | 3.48% | 12.29% | -67.34% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.20B | -7.10 | -6.45% | ― | 5.73% | -35.54% | |
54 Neutral | HK$2.53T | 2.38 | 9.95% | 1.34% | 4.59% | -16.23% | |
50 Neutral | HK$511.59B | -23.65 | -13.59% | ― | 8.12% | -166.15% | |
40 Underperform | HK$941.44M | -0.11 | ― | ― | 13.45% | 48.65% |